T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
551
DELISTED
Signature Bank
SBNY
| $106M | 0.02% |
844,618
+4,530
| +0.5% | +$605K |
|
|
ATRI
552
DELISTED
Atrion Corp
ATRI
| $104M | 0.02% |
244,096
+90
| +0% | +$36.5K |
|
553
RLJ Lodging Trust
RLJ
$1.67B
| $104M | 0.02% |
4,862,580
-309,721
| -6% | -$6.59M |
|
554
Belden
BDC
$5.36B
| $104M | 0.02% |
1,723,804
+11
| +0% | +$688 |
|
|
BECN
555
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $102M | 0.02% |
2,253,707
+10,357
| +0.5% | +$446K |
|
|
TIF
556
DELISTED
Tiffany & Co.
TIF
| $102M | 0.02% |
1,689,506
+1,211,390
| +253% | +$80.5M |
|
557
KBR
KBR
$4.81B
| $102M | 0.02% |
7,732,801
-2,520,060
| -25% | -$36.4M |
|
558
LivaNova
LIVN
$4.53B
| $101M | 0.02% |
2,020,309
+584,970
| +41% | +$29.6M |
|
|
ESRX
559
DELISTED
Express Scripts Holding Company
ESRX
| $101M | 0.02% |
1,331,110
-72,965
| -5% | -$5.36M |
|
560
Invesco
IVZ
$14.3B
| $100M | 0.02% |
3,926,604
+274,285
| +8% | +$8.14M |
|
561
Booz Allen Hamilton
BAH
$9.43B
| $99.4M | 0.02% |
3,354,872
+2,756,887
| +461% | +$78.9M |
|
562
ConocoPhillips
COP
$150B
| $99.3M | 0.02% |
2,278,432
+34,295
| +2% | +$1.51M |
|
|
QUOT
563
DELISTED
Quotient Technology Inc
QUOT
| $98.8M | 0.02% |
7,369,359
+1,628,256
| +28% | +$18.8M |
|
564
Insmed
INSM
$27.6B
| $98.7M | 0.02% |
10,010,522
+365,441
| +4% | +$4.26M |
|
565
Strategic Education
STRA
$1.86B
| $98.6M | 0.02% |
2,007,575
+28,440
| +1% | +$1.35M |
|
566
WEC Energy
WEC
$35.9B
| $98.5M | 0.02% |
1,508,346
+53,778
| +4% | +$3.23M |
|
567
Ironwood Pharmaceuticals
IRWD
$674M
| $98.1M | 0.02% |
8,956,890
+950,869
| +12% | +$9.29M |
|
|
EMC
568
DELISTED
EMC CORPORATION
EMC
| $97.7M | 0.02% |
3,594,451
-4,425,385
| -55% | -$120M |
|
569
Brown & Brown
BRO
$24B
| $97.6M | 0.02% |
5,208,202
+1,510,720
| +41% | +$26.8M |
|
570
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $97.5M | 0.02% |
77,622
+17,314
| +29% | +$21.5M |
|
571
RE/MAX Holdings
RMAX
$265M
| $97.5M | 0.02% |
2,421,252
+156,391
| +7% | +$6.01M |
|
572
Pebblebrook Hotel Trust
PEB
$2.05B
| $97.4M | 0.02% |
3,711,225
-16,820
| -0.5% | -$446K |
|
573
Southern Company
SO
$107B
| $97.4M | 0.02% |
1,815,372
+66,840
| +4% | +$3.36M |
|
574
LCI Industries
LCII
$2.6B
| $96.5M | 0.02% |
1,137,560
-2,200
| -0.2% | -$158K |
|
575
Progress Software
PRGS
$1.83B
| $96.4M | 0.02% |
3,510,857
+375,539
| +12% | +$9.65M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.